Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Controlled Substance Manufacturing
Overview
Market size
$98.7B
global, USD
CAGR
5.1%
base to forecast
Buyer power
-2.5
supplier-favoured
Suppliers
4
tracked players
Signals
12
4 high severity
Market outlook
2031$126.6B
What changed
Demand by region
North America demand45%
Europe demand25%
Asia Pacific15%
Latin America8%
Rest of world demand7%
share of global demandtotal 100%
Cost drivers
Raw Materials and Active Pharmaceutical Ingredients (APIs)35%
Regulatory Compliance and Security Control25%
Specialized Manufacturing and Quality Assurance20%
Distribution, Logistics, and Secure Transport12%
Labor and Overhead8%
share of delivered cost (analyst estimate)